Although the treatment of breast cancer has made great progress in recent years, largely because of the emergence of endocrine therapy and anti-HER2 therapy, surgical treatment is still the preferred option for non-metastatic breast cancer and is considered the foundation of subsequent comprehensive treatment. The gene discussed is ERBB2; the disease is breast cancer.